519 results
TricValve - Addressing the unmet need for patients with right heart failure and functional tricuspid regurgitation - Real-life clinical outcomes
18 May 2022 – From EuroPCR 2022
Watch this EuroPCR 2022 session to learn all about the latest treatment option for patients with severe TR, to discover the supporting clinical evidence of TricValve, and to understand how the TricValve Transcatheter Bicaval Valves System can improve patient's quality of life.
A new focus on mitral and tricuspid valve disease
18 May 2022 – From EuroPCR 2022
Find out more about the need for transcatheter replacement in the atrioventricular valves and the Intrepid programme, the potential of transvenous transseptal versus transapical access to the mitral valve, and the future of transvenous tricuspid valve replacement in this EuroPCR 2022 session.
Innovations in simulation-based training, procedural planning, monitoring and robotic PCI
17 May 2022 – From EuroPCR 2022
In this session, find out more about telemedicine, mixed reality technology in CTO proctoring, new-human grade simulator for ViV procedure planning, distance proctoring for transseptal TMVR, stent positioning assistance system, and robotic PCI.
PCR Tricuspid Focus Group update: present and future of tricuspid regurgitation treatment
17 May 2022 – From EuroPCR 2022
Follow the discussions based on the case of an 85-year-old male patient with HTN, mild secondary PAH, DCM, LVEF 45 %, and surgical bioAVR and MVR, presenting with progressive SOB and signs of right HF, severe secondary TR 4/5, and permanent AF, and note the indications of...
Native right ventricular outflow tract valve implantation
15 Jun 2022
This case has been accredited by EBAC with 1 CME credit
An 8-year-old boy with Tetralogy of Fallot underwent surgical correction with ventricular septal defect closure and transannular patch at the age of 16 months. PO was complicated by heart failure and sepsis. He now presents with mild tricuspid regurgitation...
Author
Author
PCRonline @ ACC 2022 Scientific Sessions
29 Mar 2022
Live updates on a selection of major Late Breaking Clinical Trials of interest in interventional cardiology presented at the American College of Cardiology 2022 Scientific Sessions #ACC22.
One-year results of the Clasp TR Study: Transcatheter treatment of tricuspid regurgitation
22 Mar 2022
Alessandro Sticchi and Luigi Biasco provide their take on the 1-year results of the CLASP TR study which were presented by Dr Adan Greenbaum, co-director of the Emory Structural Heart and Valve Center (Atlanta, GA) during the 2022 American College of Cardiology annual Congress held in Washington D.C.
Author
Author
A patient with multivalvular disease: which approach?
05 Apr 2022
An 81-year-old lady with past history of surgical aortic valve replacement followed by implantation of dual-chamber permanent pacemaker was admitted for recurrent episodes of right heart decompensations. The echocardiographic evaluation revealed massive TR and moderate primary MR due to a retracted posterior leaflet. What would be...
Author
Author
Right ventricular-pulmonary arterial coupling and afterload reserve in patients undergoing transcatheter tricuspid valve repair
10 Feb 2022
The authors hypothesized that disordered right ventricular to pulmonary artery (RV-PA) coupling may denote RV decompensation in patients undergoing transcatheter tricuspid valve repair (TTVR) that may correlate with poor clinical outcomes.
Reviewer
Reviewer
Cardiohepatic syndrome is associated with poor prognosis in patients undergoing tricuspid transcatheter edge-to-edge valve repair
27 Jan 2022
As the prognostic role of cardiohepatic syndrome (CHS) has not yet been evaluated, Stolz et al. in the present study assessed its impact on T-TEER outcomes.
Reviewer
Reviewer
